🔎 Trials Near Me

Home › Ovarian Cancer

Ovarian Cancer clinical trials recruiting in the U.S.

269 studies for Ovarian Cancer are recruiting participants at sites across the United States.

Ovarian cancer is a cancerous tumor that forms in the tissues of an ovary. The ovaries are a pair of female reproductive glands that make eggs and female hormones.

Cities with the most studies

By state

Recently updated studies

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07360314

DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer

RecruitingPhase 1
Ages 18 and older · Women · Updated Nov 13, 2026 · NCT06964009

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

RecruitingObservational study
Ages 2 to 100 · All sexes · Updated Nov 12, 2026 · NCT01950572

A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.

RecruitingPhase 1
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT07664735

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06270706

Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer

RecruitingPhase 2
Ages 18 to 72 · All sexes · Updated Nov 12, 2026 · NCT01174121

A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)

RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 10, 2026 · NCT07318558

Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer

RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 10, 2026 · NCT07718854

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314

Phase 1 Study of VT-101 in Advanced Ovarian Cancer

RecruitingPhase 1
Ages 18 to 99 · Women · Updated Nov 9, 2026 · NCT07905677

A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

RecruitingPhase 1
Ages 18 and older · Women · Updated Nov 9, 2026 · NCT04516447

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 6, 2026 · NCT06787612

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.